Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
48 participants
INTERVENTIONAL
2010-10-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
NCT01614847
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936
Tear Osmolarity Clinical Utility in Dry Eye Disease
NCT02417116
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518
Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
NCT00514852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Refresh tears
Allergan's Refresh tears artificial tear
Artificial tears
Instill one drop of artificial tears
Systane Ultra
Alcon's Systane Ultra artificial tear
Artificial tears
Instill one drop of artificial tears
Visine
Visine artificial tear
Artificial tears
Instill one drop of artificial tears
Blink tears
AMO's blink tears artificial tear
Artificial tears
Instill one drop of artificial tears
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artificial tears
Instill one drop of artificial tears
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
Corneal staining Grade 3 or higher No Restasis for past 3 months Discontinue topical medications for at least 1 week
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Hom, Milton M., OD, FAAO
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Private Practice
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Milton M Hom, OD FAAO
Role: PRINCIPAL_INVESTIGATOR
Private Practice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Milton M. Hom, OD, FAAO.
Azusa, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.